Literature DB >> 12900447

Wise, a context-dependent activator and inhibitor of Wnt signalling.

Nobue Itasaki1, C Michael Jones, Sara Mercurio, Alison Rowe, Pedro M Domingos, James C Smith, Robb Krumlauf.   

Abstract

We have isolated a novel secreted molecule, Wise, by a functional screen for activities that alter the anteroposterior character of neuralised Xenopus animal caps. Wise encodes a secreted protein capable of inducing posterior neural markers at a distance. Phenotypes arising from ectopic expression or depletion of Wise resemble those obtained when Wnt signalling is altered. In animal cap assays, posterior neural markers can be induced by Wnt family members, and induction of these markers by Wise requires components of the canonical Wnt pathway. This indicates that in this context Wise activates the Wnt signalling cascade by mimicking some of the effects of Wnt ligands. Activation of the pathway was further confirmed by nuclear accumulation of beta-catenin driven by Wise. By contrast, in an assay for secondary axis induction, extracellularly Wise antagonises the axis-inducing ability of Wnt8. Thus, Wise can activate or inhibit Wnt signalling in a context-dependent manner. The Wise protein physically interacts with the Wnt co-receptor, lipoprotein receptor-related protein 6 (LRP6), and is able to compete with Wnt8 for binding to LRP6. These activities of Wise provide a new mechanism for integrating inputs through the Wnt coreceptor complex to modulate the balance of Wnt signalling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900447     DOI: 10.1242/dev.00674

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  110 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 2.  The R-spondin protein family.

Authors:  Wim B M de Lau; Berend Snel; Hans C Clevers
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

3.  Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.

Authors:  Shruti Goel; Emily N Chin; Saja A Fakhraldeen; Scott M Berry; David J Beebe; Caroline M Alexander
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 4.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

5.  Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning.

Authors:  Youngwook Ahn; Brian W Sanderson; Ophir D Klein; Robb Krumlauf
Journal:  Development       Date:  2010-08-19       Impact factor: 6.868

Review 6.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

7.  Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.

Authors:  S Deasey; D Nurminsky; S Shanmugasundaram; F Lima; M Nurminskaya
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

8.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

Review 9.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

Review 10.  Wnt modulators in the biotech pipeline.

Authors:  Jean-Philippe Rey; Debra L Ellies
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.